iX Biopharma Ltd. (SGX: 42C)

iX Biopharma Revenue

In the fiscal year ending June 30, 2024, iX Biopharma had annual revenue of 5.96M SGD with 0.78% growth. iX Biopharma had revenue of 3.29M in the half year ending June 30, 2024, with 172.78% growth.

• Revenue: 5.96M
• Revenue Growth: +0.78%
• P/S Ratio: 3.09
• Revenue / Employee: 141.88K
• Employees: 42
• Market Cap: 21.20M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	5.96M	46.00K	0.78%
Jun 30, 2023	5.91M	-8.48M	-58.91%
Jun 30, 2022	14.39M	12.65M	724.64%
Jun 30, 2021	1.75M	760.00K	77.16%
Jun 30, 2020	985.00K	314.00K	46.80%